Web1 hour ago · FY23 Outlook: D-Wave expects revenue of $12 million - $13 million representing year-over-year growth of 67% to 80%. The company expects to maintain its revenue growth rate over the next several years. WebBMY Quarterly Earnings Report - Bristol Myers Squibb Investors Financial Reporting Quarterly Results Quarterly Results View our Quarterly Earnings Release and Package …
Bristol-Myers Squibb - BMY - Stock Price & News The Motley Fool
Web4 hours ago · The group forecast a revenue hit of 25 million pounds ($31.27 million) to 30 million pounds from the Middle East suspensions and said it has implemented "robust … WebCompany’s earnings for a period net of operating costs, taxes, and interest. 2.02B. -14.76%. Net profit margin. Measures how much net income or profit is generated as a percentage of revenue. 17 ... cic knoxville tn
BMY Stock: Is Bristol Myers Stock A Buy Or A Sell In September …
WebFeb 4, 2024 · The company reported non-GAAP net earnings attributable to Bristol Myers Squibb of $3.3 billion, or $1.46 per share, in the fourth quarter, compared to non-GAAP net earnings of $2.4 billion, or $1.22 per share, for the same period a year ago. ... Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, … WebOn Invalid Date, Bristol Myers Squibb Co (NYSE: BMY) reported Q4 2024 earnings per share (EPS) of $0.96, up 10.28% year over year. Total Bristol Myers Squibb Co earnings for the quarter were $2.02 billion. In the same quarter last year, Bristol Myers Squibb Co's earnings per share (EPS) was $1.07. WebNon-GAAP EPS **. 1 The 2024 financial guidance excludes the impact of any potential future strategic acquisitions and divestitures, any specified items that have not yet been identified and quantified and the impact of any future Acquired IPRD charges. 2 GAAP and non-GAAP guidance includes net impact of ($0.22) from Acquired IPRD and licensing ... dgthth